Butterfly Medical awarded CE Mark for prostate device
07:17 EST 28 Nov 2017 |
Globes
The Israeli company's innovative device is designed to dilate the prostatic urethra without surgical incision or prostate tissue removal.
Related Biotechnology, Pharmaceutical and Healthcare News
Original Article: Butterfly Medical awarded CE Mark for prostate device
NEXT ARTICLE
More From BioPortfolio on "Butterfly Medical awarded CE Mark for prostate device"